Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herling

Showing results (401-410 of 481) with videos related to

Pageof 49
Sort By:
Blood|April 6, 2023
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemiaQu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2023
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapyThomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, et al.
Immunity|October 23, 2012
A PP4 holoenzyme balances physiological and oncogenic nuclear factor-kappa B signaling in T lymphocytesMarkus Brechmann, Thomas Mock, Dorothee Nickles, et al.
BMJ Open|February 24, 2026
Predicting outcomes in selective fetal growth restriction of monoChOrioNic Twins: an inteRnAtional observational cohort STudy protocol (CONTRAST study)Anne Noll, Ali Javinani, Femke Slaghekke, et al.
European Journal of Haematology|January 14, 2022
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?Christian Brieghel, Veerle Galle, Rudi Agius, et al.
Scientific Reports|January 26, 2023
Supplementation with okra combined or not with exercise training is able to protect the heart of animals with metabolic syndromeMoisés Felipe Pereira Gomes, Elizabeth de Orleans Carvalho de Moura, Naiara Magalhães Cardoso, et al.
Research Involvement and Engagement|August 30, 2023
Patient and public involvement in Nordic healthcare research: a scoping review of contemporary practiceKristine Elberg Dengsø, Sofie Tscherning Lindholm, Suzanne Forsyth Herling, et al.
Cancers|June 10, 2023
SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-TransportersElisabeth Groß, Ralf-Axel Hilger, Franziska Lea Schümann, et al.
Leukemia & Lymphoma|September 21, 2018
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenanceNatali Pflug, Paula Cramer, Sandra Robrecht, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 26, 2017
Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registryChiara Melloni, Peter Shrader, Joseph Carver, et al.
Pageof 49

Showing results (401-410 of 481) with videos related to

Sort By:
Pageof 49
Blood|April 6, 2023
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemiaQu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, et al.
Journal of Cancer Research and Clinical Oncology|January 20, 2023
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapyThomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, et al.
Immunity|October 23, 2012
A PP4 holoenzyme balances physiological and oncogenic nuclear factor-kappa B signaling in T lymphocytesMarkus Brechmann, Thomas Mock, Dorothee Nickles, et al.
BMJ Open|February 24, 2026
Predicting outcomes in selective fetal growth restriction of monoChOrioNic Twins: an inteRnAtional observational cohort STudy protocol (CONTRAST study)Anne Noll, Ali Javinani, Femke Slaghekke, et al.
European Journal of Haematology|January 14, 2022
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?Christian Brieghel, Veerle Galle, Rudi Agius, et al.
Scientific Reports|January 26, 2023
Supplementation with okra combined or not with exercise training is able to protect the heart of animals with metabolic syndromeMoisés Felipe Pereira Gomes, Elizabeth de Orleans Carvalho de Moura, Naiara Magalhães Cardoso, et al.
Research Involvement and Engagement|August 30, 2023
Patient and public involvement in Nordic healthcare research: a scoping review of contemporary practiceKristine Elberg Dengsø, Sofie Tscherning Lindholm, Suzanne Forsyth Herling, et al.
Cancers|June 10, 2023
SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-TransportersElisabeth Groß, Ralf-Axel Hilger, Franziska Lea Schümann, et al.
Leukemia & Lymphoma|September 21, 2018
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenanceNatali Pflug, Paula Cramer, Sandra Robrecht, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 26, 2017
Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registryChiara Melloni, Peter Shrader, Joseph Carver, et al.
Pageof 49